takeda seeks global reach with $12 billion nycomed bid
japan's largest drugmaker takeda pharmaceutical is in talks to buy privately held swiss rival nycomed for more than $12 billion to extend its global reach into europe and emerging markets, according to sources with direct knowledge of the matter.
http://feeds.reuters.com/~r/reuters/businessnews/~3/ui0cwrfiku8/us-nycomed-takeda-idustre74b0ad20110512
18739
12 May 2011 18:01:15
reuters
business